🔎 Trials Near Me

Beranda › Sistem Imun dan Gangguan › Illinois

Uji klinis Sistem Imun dan Gangguan di Illinois

9 studi untuk Sistem Imun dan Gangguan mencari peserta di lokasi di Illinois.

Kota di Illinois

Teks studi resmi (Bahasa Inggris)

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • OSF Saint Anthony's Health Center, Alton
  • Rush-Copley Medical Center, Aurora
  • Advocate Outpatient Center - Aurora, Aurora
  • dan 49 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04242095

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

  • University of Illinois Hospital & Health Sciences System, Chicago
Menerima pesertaFase 1/2
Usia 35 hingga 70 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT06575426

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • University of Chicago Medical Center, Chicago
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT04104776

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  • Inmagene Site 2, Rolling Meadows
Menerima pesertaFase 2
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT07037901

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Northwestern Memorial Hospital, Chicago
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT03328078

Study of Gastric Motility in Eosinophilic Gastritis

  • Northwestern University, Chicago
Menerima pesertaStudi observasional
Usia 18 hingga 59 · Semua jenis kelamin · Diperbarui 31 Mar 2026 · NCT05229432

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • University of Illinois Medical Center - Hematology & Oncology, Chicago
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT06619561

Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • University of Chicago, Chicago
Menerima pesertaFase 4
Semua usia · Semua jenis kelamin · Diperbarui 14 Mei 2009 · NCT00004317

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.